The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 786-791

  Meissner, Torsten B ^a,b   Li, Amy ^a   Liu, Yuen Joyce ^a   Gagnon, Etienne ^a,c   Kobayashi, Koichi S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

CITA; MHC class I; NLR proteins

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEOTIDE BINDING PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; GENES, MHC CLASS I; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEOTIDES; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION;

EID: 84862777568     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.104     Document Type: Article

References (27)

1. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993, 11:403-450.
2. Oldstone M.B. Virus-lymphoid cell interactions. Proc. Natl. Acad. Sci. USA 1996, 93:12756-12758.
3. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993, 75:135-146.
4. Beresford G.W., Boss J.M. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2001, 2:652-657.
5. Masternak K., Muhlethaler-Mottet A., Villard J., Zufferey M., Steimle V., Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes. Dev. 2000, 14:1156-1166.
6. Reith W., Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001, 19:331-373.
7. Ting J.P., Trowsdale J. Genetic control of MHC class II expression. Cell 2002, 109(Suppl.):S21-S33.
8. Boss J.M., Jensen P.E. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 2003, 15:105-111.
9. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997, 6:591-600.
10. van den Elsen P.J., Gobin S.J., van Eggermond M.C., Peijnenburg A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 1998, 48:208-221.
11. van den Elsen P.J., Peijnenburg A., van Eggermond M.C., Gobin S.J. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 1998, 19:308-312.
12. Gobin S.J., Peijnenburg A., Keijsers V., van den Elsen P.J. Site alpha is crucial for two routes of IFN-gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997, 6:601-611.
13. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 1991, 88:4285-4288.
14. Chang C.H., Guerder S., Hong S.C., van Ewijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996, 4:167-178.
15. Itoh-Lindstrom Y., Piskurich J.F., Felix N.J., Wang Y., Brickey W.J., Platt J.L., Koller B.H., Ting J.P. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 1999, 163:2425-2431.
16. Williams G.S., Malin M., Vremec D., Chang C.H., Boyd R., Benoist C., Mathis D. Mice lacking the transcription factor CIITA-a second look. Int. Immunol. 1998, 10:1957-1967.
17. Meissner T.B., Li A., Biswas A., Lee K.H., Liu Y.J., Bayir E., Iliopoulos D., van den Elsen P.J., Kobayashi K.S. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 2010, 107:13794-13799.
18. T.B. Meissner, A. Li, K.S. Kobayashi, NLRC5: a newly discovered MHC class I transactivator (CITA). Microbes Infect 2011. in press.
19. Wilmanski J.M., Petnicki-Ocwieja T., Kobayashi K.S. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol. 2008, 83:13-30.
20. Ting J.P., Lovering R.C., Alnemri E.S., Bertin J., Boss J.M., Davis B.K., Flavell R.A., Girardin S.E., Godzik A., Harton J.A., Hoffman H.M., Hugot J.P., Inohara N., Mackenzie A., Maltais L.J., Nunez G., Ogura Y., Otten L.A., Philpott D., Reed J.C., Reith W., Schreiber S., Steimle V., Ward P.A. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287.
21. Bewry N.N., Bolick S.C., Wright K.L., Harton J.A. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter. J. Biol. Chem. 2007, 282:26178-26184.
22. Harton J.A., Cressman D.E., Chin K.C., Der C.J., Ting J.P. GTP binding by class II transactivator: role in nuclear import. Science 1999, 285:1402-1405.
23. Cressman D.E., Chin K.C., Taxman D.J., Ting J.P. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 1999, 10:163-171.
24. Spilianakis C., Papamatheakis J., Kretsovali A. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol. Cell. Biol. 2000, 20:8489-8498.
25. Hake S.B., Masternak K., Kammerbauer C., Janzen C., Reith W., Steimle V. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol. Cell. Biol. 2000, 20:7716-7725.
26. Davis B.K., Roberts R.A., Huang M.T., Willingham S.B., Conti B.J., Brickey W.J., Barker B.R., Kwan M., Taxman D.J., Accavitti-Loper M.A., Duncan J.A., Ting J.P. Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 2011, 186:1333-1337.
27. Vinkemeier U. Getting the message across, STAT! Design principles of a molecular signaling circuit. J. Cell Biol. 2004, 167:197-201.